image
NRx Pharmaceuticals, Inc. NRXPW
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.05
-37.5 %
$ 8.89 M
Market Cap
-0.01
P/E
BALANCE SHEET
7.32 M ASSETS
-71.66%
Growth Rates
1Year -71.66%
3Years 35.49%
5Years -36.49%
7Years 0.00%
10Years 0.00%
19 M LIABILITIES
3.48%
Growth Rates
1Year 3.48%
3Years -25.85%
5Years 72.22%
7Years 0.00%
10Years 0.00%
-11.7 M EQUITY
-158.36%
Growth Rates
1Year -158.36%
3Years 35.52%
5Years -3.17%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition NRx Pharmaceuticals, Inc.
image
Current Assets 6.88 M
Cash & Short-Term Investments 4.6 M
Receivables 0
Other Current Assets 2.29 M
Non-Current Assets 431 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 431 K
Current Liabilities 19 M
Accounts Payable 4.63 M
Short-Term Debt 9.16 M
Other Current Liabilities 5.26 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 4.6 20.1 27.6 1.9 6 11.1 K 0.4
Short Term Investments 0 0 0 6.0 32.0 70.8 69.0
Receivables 0 0 0 0.8 0 0 0
Inventory 0 7 K 0 0.2 0 0 0
Other Current Assets 2.3 11.5 5.1 0.2 69.5 K 19.1 K 87 K
Total Current Assets 6.9 25.8 32.7 2.9 69.5 K 30.2 K 0.5
PP&E 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 32.0 70.8 69.0
Other Long Term Assets 0.4 21 K 15 K 11 K 1 0 0
Other Assets 0 0 0 0 0 0 0
Total Assets 7.3 25.8 32.7 2.9 32.1 70.8 69.6
LIABILITIES
Accounts Payable 4.6 2.1 3.7 3.2 0.6 0.6 85.7 K
Short Term Debt 9.2 7.7 0.5 0.2 0 0 0
Other Current Liabilities 5.3 5.8 7.7 42.7 69.5 K 0 7.5 K
Total Current Liabilities 19.0 16.6 11.9 46.2 0.6 0.6 93.2 K
Long Term Debt 0 2.8 0 0.5 2.0 0.7 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0
Total Liabilities 19.0 18.4 11.9 46.7 2.6 1.3 93.2 K
EQUITY
Common Stock 84 K 67 K 59 K 43 K 24.5 64.5 64.5
Retained Earnings (253.1) (223.1) (183.2) (90.2) 0.4 38.9 K (0.1)
Other Accumulative Comprehensive Income/Loss 3 K 0 0 0 (24.5) 0 0
Total Equity (11.7) 7.4 20.8 (43.8) 29.5 69.5 69.5
Total Liabilities and Equity 7.3 25.8 32.7 2.9 32.1 70.8 69.6
SHARES OUTSTANDING
Common Shares Outstanding 7.6 65.8 46.9 34.3 0.5 0.9 0.9